Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NeoImmuneTech
Yale University
Amgen
The University of Texas Health Science Center at San Antonio
Columbia University
Emory University
University of Washington
Stanford University
M.D. Anderson Cancer Center
Emory University
University of Kentucky
Merck Sharp & Dohme LLC
Indiana University
Baylor College of Medicine
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb
Stanford University
University of California, San Diego
Institut Bergonié
Emory University
Palleon Pharmaceuticals, Inc.
Massachusetts General Hospital
Mayo Clinic
University of California, San Diego
Sichuan Enray Pharmaceutical Sciences Company
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Trishula Therapeutics, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Chicago
Trishula Therapeutics, Inc.
University of Colorado, Denver
Pfizer
NGM Biopharmaceuticals, Inc
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
ImmunoGenesis
Thomas Jefferson University
Thomas Jefferson University
BPGbio
Intensity Therapeutics, Inc.
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
BerGenBio ASA
Stanford University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Hoosier Cancer Research Network
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Bruckner Oncology